Ban & Monetization Policy
MyLiveRoom Rewards Program Rules & Eligibility
0 Σχόλια
0 Μοιράστηκε
326 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Late-Stage Oncology Drug Pipeline Market Trends to Watch: Growth, Share, Segments and Forecast Data" According to the latest report published by Data Bridge Market Research, the Late-Stage Oncology Drug Pipeline Market The global late-stage oncology drug pipeline market size was valued at USD 10.85 billion in 2025 and is expected to reach USD 26.67 billion by 2033, at a CAGR of 11.90% during the forecast period For an effectual business growth, companies...0 Σχόλια 0 Μοιράστηκε 214 Views 0 Προεπισκόπηση
-
Precision Oncology Drug Portfolio Market Size, Industry Development and Forecast Insights"Executive Summary Precision Oncology Drug Portfolio Market Market: Share, Size & Strategic Insights The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the forecast period This Precision Oncology Drug Portfolio Market Market...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
-
Anal Cancer Drug Market: Chemotherapy, Targeted Therapies, and Immunotherapy Treatment Strategies in Oncology"Executive Summary Anal Cancer Drug Market Research: Share and Size Intelligence The global anal cancer drug market size was valued at USD 401.57 million in 2024 and is projected to reach USD 1,199.82 million by 2032, with a CAGR of 13.80 % during the forecast period of 2025 to 2032. Best-practice models and research methodologies have been employed in the reliable Anal Cancer Drug Market...0 Σχόλια 0 Μοιράστηκε 3χλμ. Views 0 Προεπισκόπηση
-
Chemotherapy Market Outlook 2034: Advances in Drug Delivery Transform Oncology TherapiesThe global chemotherapy market is witnessing steady expansion as the growing prevalence of cancer, increasing healthcare investments, and continuous advancements in oncology therapies reshape the global treatment landscape. Chemotherapy remains one of the most widely adopted cancer treatment approaches, either as a standalone therapy or in combination with surgery, radiation therapy,...0 Σχόλια 0 Μοιράστηκε 200 Views 0 Προεπισκόπηση
-
Could Novel Therapies Redefine Outcomes in the Hormone-Refractory Oncology Drug Market?According to the latest report published by Data Bridge Market Research, the Hormone-Refractory Oncology Drug Market CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period The Hormone-Refractory Oncology Drug Market report not...0 Σχόλια 0 Μοιράστηκε 257 Views 0 Προεπισκόπηση
-
First-in-Class Oncology Drug Market Size, Share, Trends, Growth Opportunities, Key Drivers and Competitive Outlook" According to the latest report published by Data Bridge Market Research, the First-in-Class Oncology Drug Market The global first-in-class oncology drug market size was valued at USD 8.67 billion in 2025 and is expected to reach USD 25.08 billion by 2033, at a CAGR of14.20% during the forecast periodThe market growth is largely fueled by rapid advancements in drug discovery...0 Σχόλια 0 Μοιράστηκε 176 Views 0 Προεπισκόπηση
-
Generic Oncology Drugs Market Segmentation Analysis: Insights by Drug Type, Indication, and Distribution ChannelThe global generic oncology drugs market is structured across multiple segments that reflect the diversity of cancer treatments and the evolving needs of patients and healthcare providers. Increasing demand for cost-effective therapies and the growing prevalence of various cancer types are driving growth across all segments. Generic Oncology Drugs Market Segmentation Analysis provides...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Kirsten Rat Sarcoma (KRAS) Market: Targeted Therapies, Next-Generation Inhibitors (G12C), and Oncology Drug Development"Executive Summary Kirsten Rat Sarcoma (KRAS) Market Size and Share: Global Industry Snapshot Global Kirsten Rat Sarcoma (KRAS) market size was valued at USD 3.69 billion in 2024 and is projected to reach USD 3.37 billion by 2032, with a CAGR of 1.5% during the forecast period of 2025 to 2032. Kirsten Rat Sarcoma (KRAS) Market report offers the most appropriate solution for the...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
-
Lurbinectedin Market Size, Share, Cancer Therapeutics Innovation & Oncology Drug Development Trends | Industry Forecast to 2029The Lurbinectedin Market has emerged as a notable niche within the oncology therapeutics landscape, driven by advancements in targeted cancer treatments and rising incidence of small cell lung cancer (SCLC) and select solid tumors. The lurbinectedin market is expected to witness market growth at a rate of 45.30% in the forecast period of 2022 to...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
-
Dasatinib Market Forecast Based on Increasing Cancer Incidence WorldwideThe global Dasatinib Market was valued at USD 5.6 billion in 2025 and is projected to reach USD 7.6 billion by 2033, expanding at a CAGR of 4.3% from 2026 to 2033. The market is witnessing steady growth due to the increasing prevalence of hematologic cancers, particularly Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)....0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Asia-Pacific PDX Models Market Accelerates with Rising Oncology Research InvestmentsAccording to the latest report published by Data Bridge Market Research, the Asia-Pacific Patient Derived Xenograft (PDX) Models Market CAGR Value To impart a supreme quality to this persuasive Asia-Pacific Patient Derived Xenograft (PDX) Models Market report, unswerving efforts of enthusiastic, dynamic and skilled researchers and analysts have been utilized. Evaluations...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
-
Carcinoid Syndrome Drug Market Gains Momentum with Advancements in Targeted TherapiesAccording to the latest report published by Data Bridge Market Research, the Carcinoid Syndrome Drug Market CAGR Value This Carcinoid Syndrome Drug Market research report is a resource, which offers current as well as upcoming technical and financial details of the Carcinoid Syndrome Drug Market industry for the specific forecast period. The report exhibits important product...0 Σχόλια 0 Μοιράστηκε 3χλμ. Views 0 Προεπισκόπηση
-
Clinical Trials Site Market Developments Across Healthcare Research NetworksThe global clinical trials site market size was valued at USD 6.72 billion in 2024 and is projected to grow from USD 7.14 billion in 2025 to USD 11.57 billion by 2033 at a CAGR of 6.22% during the forecast period (2025-2033). Key Highlights North America dominated the global clinical trials site market. Asia-Pacific is expected to be the fastest-growing region during the forecast...0 Σχόλια 0 Μοιράστηκε 4χλμ. Views 0 Προεπισκόπηση
-
Emerging Trends Influencing the Antibody Drug Conjugates MarketAsia-Pacific is expected to witness rapid growth in the coming years due to increasing healthcare investments and expanding pharmaceutical manufacturing capabilities. Countries like China and India are emerging as important research hubs. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...0 Σχόλια 0 Μοιράστηκε 10χλμ. Views 0 Προεπισκόπηση
-
Endocrine Resistance–Targeting Drug Market Advances Through Breast Cancer ResearchAccording to the latest report published by Data Bridge Market Research, the Endocrine Resistance–Targeting Drug Market CAGR Value An excellent Endocrine Resistance–Targeting Drug Market research report is a great store to acquire current as well as upcoming technical and financial details and market insights of the Endocrine Resistance–Targeting Drug...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
Αναζήτηση αποτελεσμάτων
© 2026 Myliveroom — Live Events & Online Communities
Greek
Greek
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
